Biblio

Export 436 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Keyword is S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
N
D. A. Nation, Tan, A., Dutt, S., McIntosh, E. C., Yew, B., Ho, J. K., Blanken, A. E., Jang, J. Yun, Rodgers, K. E., and Gaubert, A., “Circulating Progenitor Cells Correlate with Memory, Posterior Cortical Thickness, and Hippocampal Perfusion.”, J Alzheimers Dis, vol. 61, no. 1, pp. 91-101, 2018.
S. X. Naughton, Raval, U., and Pasinetti, G. M., “Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies.”, J Alzheimers Dis, vol. 76, no. 1, pp. 21-25, 2020.
S. X. Naughton, Raval, U., and Pasinetti, G. M., “Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies.”, J Alzheimers Dis, vol. 76, no. 1, pp. 21-25, 2020.
P. Y. Ng, Zhang, C., Li, H., and Baker, D. J., “Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1751-1763, 2024.
L. Ni, Liu, R., Yin, Z., Zhao, H., Nedelska, Z., Hort, J., Zhou, F., Wu, W., Zhang, X., Li, M., Yu, H., Zhu, B., Xu, Y., and Zhang, B., “Aberrant Spontaneous Brain Activity in Patients with Mild Cognitive Impairment and concomitant Lacunar Infarction: A Resting-State Functional MRI Study.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1243-54, 2016.
E. Niemantsverdriet, Goossens, J., Struyfs, H., Martin, J. - J., Goeman, J., De Deyn, P. Paul, Vanderstichele, H., and Engelborghs, S., “Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 97-106, 2016.
J. Ning, Huang, S. - Y., Chen, S. - D., Zhang, Y. - R., Huang, Y. - Y., and Yu, J. - T., “Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study.”, J Alzheimers Dis, vol. 87, no. 1, pp. 211-222, 2022.
J. Nishihira, Tokashiki, T., Higashiuesato, Y., Willcox, D. Craig, Mattek, N., Shinto, L., Ohya, Y., and Dodge, H. H., “Associations between Serum Omega-3 Fatty Acid Levels and Cognitive Functions among Community-Dwelling Octogenarians in Okinawa, Japan: The KOCOA Study.”, J Alzheimers Dis, vol. 51, no. 3, pp. 857-66, 2016.
G. Novak, Fox, N., Clegg, S., Nielsen, C., Einstein, S., Lu, Y., Tudor, I. Cristina, Gregg, K., Di, J., Collins, P., Wyman, B. T., Yuen, E., Grundman, M., H Brashear, R., and Liu, E., “Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1123-34, 2016.
K. Nunez, Kay, J., Krotow, A., Tong, M., Agarwal, A. R., Cadenas, E., and de la Monte, S. M., “Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 151-63, 2016.
K. Nunez, Kay, J., Krotow, A., Tong, M., Agarwal, A. R., Cadenas, E., and de la Monte, S. M., “Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 151-63, 2016.
K. Nunez, Kay, J., Krotow, A., Tong, M., Agarwal, A. R., Cadenas, E., and de la Monte, S. M., “Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 151-63, 2016.
O
R. O'Caoimh, Timmons, S., and D Molloy, W., “Screening for Mild Cognitive Impairment: Comparison of "MCI Specific" Screening Instruments.”, J Alzheimers Dis, vol. 51, no. 2, pp. 619-29, 2016.
R. Olmos-Villaseñor, Sepulveda-Silva, C., Julio-Ramos, T., Fuentes-Lopez, E., Toloza-Ramirez, D., Santibañez, R. A., Copland, D. A., and Mendez-Orellana, C., “Phonological and Semantic Fluency in Alzheimer's Disease: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 95, no. 1, pp. 1-12, 2023.
S. V. Ovsepian and O'Leary, V. B., “Neuronal activity and amyloid plaque pathology: an update.”, J Alzheimers Dis, vol. 49, no. 1, pp. 13-9, 2016.
P
M. Pacheco-Herrero, Soto-Rojas, L. O., Reyes-Sabater, H., Garcés-Ramirez, L., López, Fde la Cruz, Villanueva-Fierro, I., and Luna-Muñoz, J., “Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease.”, J Alzheimers Dis, vol. 84, no. 3, pp. 917-935, 2021.
E. L. Paley, Merkulova-Rainon, T., Faynboym, A., Shestopalov, V. I., and Aksenoff, I., “Geographical Distribution and Diversity of Gut Microbial NADH:Ubiquinone Oxidoreductase Sequence Associated with Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1531-1540, 2018.
S. G. Papageorgiou, Voskou, P., Economou, A., Beratis, I., and Douzenis, A., “Testamentary Capacity Assessment Tool (TCAT): A Brief Instrument for Patients with Dementia.”, J Alzheimers Dis, vol. 61, no. 3, pp. 985-994, 2018.
Y. Shin Park, Joo, H. Jin, Jang, Y. Seo, Jeon, H., Park, E. - C., and Shin, J., “Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea.”, J Alzheimers Dis, vol. 97, no. 1, pp. 273-281, 2024.
Y. Shin Park, Joo, H. Jin, Jang, Y. Seo, Jeon, H., Park, E. - C., and Shin, J., “Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea.”, J Alzheimers Dis, vol. 97, no. 1, pp. 273-281, 2024.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., “Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., “Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P., “MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”, J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
A. Pedrinolla, Venturelli, M., Fonte, C., Munari, D., Benetti, M. Vittoria, Rudi, D., Tamburin, S., Muti, E., Zanolla, L., Smania, N., and Schena, F., “Exercise Training on Locomotion in Patients with Alzheimer's Disease: A Feasibility Study.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1599-1609, 2018.
J. Peter, Schumacher, L. V., Landerer, V., Abdulkadir, A., Kaller, C. P., Lahr, J., and Klöppel, S., “Biological Factors Contributing to the Response to Cognitive Training in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 1, pp. 333-345, 2018.

Pages